Update: The NIH sent a response to our comments, available here. The response fails to address the glaring lack of information available regarding Retargeted Therapeutics. On June 8, 2020, Knowledge Ecology International and the Union for Affordable Cancer Treatment (UACT)… Continue Reading
On Thursday, 18 June 2020, the Senate Foreign Relations Committee convened a hearing on COVID-19 and U.S. International Pandemic Preparedness, Prevention, and Response. The witnesses called to provide testimony included: 1) James L. Richardson, Director, Office of Foreign Assistance, U.S.… Continue Reading
Other Transaction Agreements: Government Contracts that May Eliminate Protections for the Public on Pricing, Access and Competition, Including in Connection with COVID-19 KEI Briefing Note 2020:3 June 29, 2020 (revision of June 24 version) Kathryn Ardizzone James Love The most… Continue Reading
On Friday, 19 June 2020, the World Trade Organization (WTO) convened an informal virtual Open-ended Meeting of the TRIPS Council. . The following statements were delivered by South Africa at the virtual open-ended informal meeting of the TRIPS Council. In… Continue Reading
On Thursday, 4 June 2020, the United Kingdom of Great Britain and Northern Ireland hosted the Global Vaccines Summit which successfully raised $US 8.8 billion for Gavi, the Vaccine Alliance – breaking the original fundraising target of $US 7.4 billion.… Continue Reading
On 14 May 2020, Bernd Lange, Chair of the European Parliament’s Committee on International Trade (INTA) wrote a letter to Phil Hogan (Commissioner for Trade, European Commission) on the “commercial aspects of intellectual property rights for medical products in the… Continue Reading
Statement of Knowledge Ecology International (KEI) on WHO Launch of the COVID-19 Technology Pool May 29, 2020. KEI supports the “WHO Solidarity Call to Action: To realize equitable global access to COVID-19 health technologies through pooling of knowledge, intellectual property… Continue Reading
At a May 28,2020 press briefing organized by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), pharma CEOs and the IFPMA DG commented on the WHO proposal for a global pool for rights in technologies for the diagnosis, prevention… Continue Reading
KEI Research Note 2020:2 Role of Private Sector, Governments and Charities in Funding Research and Development Related to Tocilizumab Luis Gil Abinader, May 28, 2020. From the Introduction: The funding of R&D for tocilizumab can be described as having three… Continue Reading
(More on Moderna here: https://www.keionline.org/moderna) (Updated to include modernatx patents) The biotech company Moderna is in the news this week, after making an announcement of early clinical results for mRNA-1273, a vaccine candidate against novel coronavirus (SARS-CoV-2). The early and… Continue Reading